Weight Loss & Metabolic
Tirzepatide
Evidence Level
Category
Weight Loss & Metabolic
How It Works
Dual incretin agonist targeting both GLP-1 and GIP receptors for enhanced metabolic effects beyond single-agonist peptides.
Medical Disclaimer: The information on this page is for educational purposes only and does not constitute medical advice. Peptide therapies have not been evaluated by the FDA for most listed indications. Always consult a licensed healthcare provider before starting any peptide protocol.
Ready to explore Tirzepatide with a provider?
Take our 2-minute quiz to get matched with a board-certified provider specializing in Tirzepatide.
Take the Quiz →